Bone mineralization in children with Wilson's disease

Area of Science:

• Pediatric Endocrinology
• Hepatology
• Bone Metabolism

Background:

• Wilson's disease (WD) is a genetic disorder of copper metabolism.
• Bone health is a potential concern in children with chronic diseases.
• Assessing bone mineralization is crucial for managing pediatric WD patients.

Purpose of the Study:

• To evaluate bone mineralization in children diagnosed with Wilson's disease.
• To investigate the influence of hypercalciuria and cirrhosis on bone mineral content (BMC) and bone mineral density (BMD) in pediatric WD.

Main Methods:

• Dual-energy X-ray absorptiometry (DXA) was used to measure BMC and BMD in 27 children with WD.
• Age- and gender-matched healthy controls were included for comparison.
• Urinary calcium excretion was assessed, and the impact of cirrhosis and hypercalciuria on bone parameters was analyzed.

Main Results:

• No significant differences in mean BMC and BMD were found between children with WD and healthy controls.
• Nearly half of the WD patients exhibited hypercalciuria.
• Hypercalciuric patients showed significantly lower BMC and BMD compared to non-hypercalciuric patients, an effect that persisted after certain adjustments.

Conclusions:

• Bone mineralization (BMC and BMD) is generally normal in children with Wilson's disease.
• Hypercalciuria, rather than cirrhosis, appears to be a significant factor negatively affecting bone health in pediatric WD patients.